Eli Lilly and Company (LLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2000 | 06-2000 | 03-2000 | 12-1999 | 09-1999 | |
| Sales | 2,811,900 | 2,621,500 | 2,451,100 | 2,820,500 | 2,585,200 |
| Cost of Goods | 490,100 | 491,700 | 508,700 | 565,200 | 548,200 |
| Gross Profit | 2,321,800 | 2,129,800 | 1,942,400 | 2,255,300 | 2,037,000 |
| Operating Expenses | 1,306,500 | 1,304,900 | 1,147,500 | 1,286,000 | 1,139,500 |
| Operating Income | 1,015,400 | 825,600 | 795,600 | 969,500 | 897,700 |
| Interest Expense | 44,100 | 45,500 | 46,800 | 51,000 | 45,900 |
| Other Income | 27,100 | 74,000 | 273,700 | 105,200 | 87,400 |
| Pre-tax Income | 998,400 | 854,100 | 1,022,500 | 1,023,700 | 939,200 |
| Income Tax | 219,600 | 187,900 | 177,000 | 237,400 | 206,600 |
| Net Income Continuous | 778,800 | 666,200 | 845,500 | 786,300 | 732,600 |
| Net Income | $778,800 | $666,200 | $845,500 | $786,300 | $732,600 |
| EPS Basic Total Ops | 0.72 | 0.62 | 0.78 | 0.73 | 0.68 |
| EPS Basic Continuous Ops | 0.72 | 0.62 | 0.78 | 0.73 | 0.68 |
| EPS Diluted Total Ops | 0.71 | 0.61 | 0.77 | 0.71 | 0.67 |
| EPS Diluted Continuous Ops | 0.71 | 0.61 | 0.77 | 0.71 | 0.67 |
| EBITDA(a) | $1,137,900 | $946,800 | $911,800 | $1,068,800 | $1,013,700 |